Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
Corinne Beinat, Samuel D. Banister, Marco Herrera-Barrera, et al.
CNS Drugs (2015) Vol. 29, Iss. 7, pp. 529-542
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes, Richard Drake, Carol Paton, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 3-78
Open Access | Times Cited: 513
Septal Cholinergic Neuromodulation Tunes the Astrocyte-Dependent Gating of Hippocampal NMDA Receptors to Wakefulness
Thomas Papouin, Jaclyn M. Dunphy, Michaela Tolman, et al.
Neuron (2017) Vol. 94, Iss. 4, pp. 840-854.e7
Open Access | Times Cited: 221
Treating Negative Symptoms in Schizophrenia: an Update
Gary Remington, George Foussias, Gagan Fervaha, et al.
Current Treatment Options in Psychiatry (2016) Vol. 3, Iss. 2, pp. 133-150
Open Access | Times Cited: 154
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
Hans O. Kalkman, Dominik Feuerbach
Cellular and Molecular Life Sciences (2016) Vol. 73, Iss. 13, pp. 2511-2530
Open Access | Times Cited: 153
GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia
Mengyi Xu, Albert H.C. Wong
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 5, pp. 733-753
Open Access | Times Cited: 108
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives
Vinay Parikh, Munir Gunes Kutlu, Thomas J. Gould
Schizophrenia Research (2016) Vol. 171, Iss. 1-3, pp. 1-15
Open Access | Times Cited: 86
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Alice Egerton, Anthony A. Grace, James Stone, et al.
Schizophrenia Research (2020) Vol. 223, pp. 59-70
Open Access | Times Cited: 85
Nicotine’s effect on cognition, a friend or foe?
Qian Wang, Weihong Du, Hao Wang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 124, pp. 110723-110723
Closed Access | Times Cited: 27
The Protective Effect of Alpha 7 Nicotinic Acetylcholine Receptor Activation on Critical Illness and Its Mechanism
Chao Ren, Yalin Tong, Juncong Li, et al.
International Journal of Biological Sciences (2016) Vol. 13, Iss. 1, pp. 46-56
Open Access | Times Cited: 74
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 7, pp. 656-667
Open Access | Times Cited: 53
PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans
Ansel T. Hillmer, Songye Li, Ming‐Qiang Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. 6, pp. 1042-1050
Open Access | Times Cited: 52
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
Antón L. Martínez, José Brea, Sara Rico, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9905-9905
Open Access | Times Cited: 34
Microwave-Assisted Synthesis of 5-Substituted 3-Amino-1,2,4-triazoles from Aminoguanidine Bicarbonate and Carboxylic Acids
Mustafa Kemal Gümüş, Nikolay Yu. Gorobets, Nesimi Uludağ
Processes (2024) Vol. 12, Iss. 3, pp. 573-573
Open Access | Times Cited: 5
Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [18F]-VAT
Jodi J. Weinstein, Scott J. Moeller, Greg Perlman, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 5, pp. 352-364
Closed Access | Times Cited: 4
Electrochemical γ-Selective Deuteration of Pyridines
Lingling Shi, Mian Liu, Lianyou Zheng, et al.
Organic Letters (2024) Vol. 26, Iss. 20, pp. 4318-4322
Closed Access | Times Cited: 4
Alkaloids from cigar
Qing‐Yang Wu, Guanghai Zhang, Feng Wei, et al.
Journal of Asian Natural Products Research (2025), pp. 1-9
Closed Access
Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation
Han Xie, Natesh Yepuri, Qinghe Meng, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 4, pp. 431-447
Open Access | Times Cited: 32
Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood–Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss
Shuang Chen, Yanyun Sun, Fei Li, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 7, pp. 2407-2422
Open Access | Times Cited: 25
Activation of the α7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration
Aobing Yang, Chia-Hsien Wu, S. Matsuo, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112555-112555
Closed Access | Times Cited: 3
Nicotinic acetylcholine receptors in the brain
Francisco J. Barrantes
Handbook of clinical neurology (2025), pp. 37-54
Closed Access
Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With Schizophrenia
Seth C. Hopkins, Ajay Ogirala, Antony Loebel, et al.
Schizophrenia Bulletin (2017) Vol. 44, Iss. 3, pp. 593-602
Open Access | Times Cited: 32
Activation of Alpha-7 Nicotinic Acetylcholine Receptor Reduces Brain Edema in Mice with Ischemic Stroke and Bone Fracture
Dingquan Zou, Man Luo, Zhenying Han, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 10, pp. 8278-8286
Open Access | Times Cited: 30
iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context
Ivanna Ihnatovych, Tapan K. Nayak, Aya Ouf, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Additive counteraction by α7 and α4β2-nAChRs of the hypotension and cardiac sympathovagal imbalance evoked by endotoxemia in male rats
Marwa Y. Sallam, Sahar M. El‐Gowilly, Hanan M. El‐Gowelli, et al.
European Journal of Pharmacology (2018) Vol. 834, pp. 36-44
Closed Access | Times Cited: 28
Activation of Central Alpha 7 Nicotinic Acetylcholine Receptor Reverses Suppressed Immune Function of T Lymphocytes and Protects Against Sepsis Lethality
Chao Ren, Xiuhua Li, Shibin Wang, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 7, pp. 748-759
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top